Company page

Statera Biopharma, Inc.

Statera Biopharma, Inc. (Ticker: STAB) is a public company based in the United States, with a market capitalization of approximately $7.14 billion. The company focuses on developing innovative therapies aimed at improving patient outcomes. Statera Biopharma is committed to advancing its research and product pipeline to address unmet medical needs.